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Abstract 21 
Acanthamoeba castellanii is a free-living ubiquitous amoeba, with a worldwide distribution, 22 
that can occasionally infect humans, causing particularly severe infections in immune 23 
compromised individuals. Dissecting the immunology of Acanthamoeba infections has been 24 
considered problematic due to the very low incidence of disease despite the high exposure rates. 25 
Whilst macrophages are acknowledged as playing a significant role in Acanthamoeba infections 26 
little is known about how this facultative parasite influences macrophage activity. Therefore, in 27 
this study we investigate the effects of Acanthamoeba on the activation of resting macrophages. 28 
Consequently, murine bone marrow derived macrophages were co-cultured with trophozoites 29 
of either the laboratory Neff strain, or a clinical isolate of A. castellanii. In vitro real-time 30 
imaging demonstrated that trophozoites of both strains often established evanescent contact with 31 
macrophages. Both Acanthamoeba strains induced a pro-inflammatory macrophage phenotype 32 
characterized by significant production of IL-12 and IL-6.  However, macrophages co-cultured 33 
with the clinical isolate of Acanthamoeba produced significantly less IL-12 and IL-6 in 34 
comparison to the Neff strain. The utilization of macrophages derived from MyD88, TRIF, 35 
TLR2, TLR4, TLR2/4 deficient mice indicated that Acanthamoeba-induced pro-inflammatory 36 
cytokine production was through MyD88-dependent, TRIF independent, TLR4-induced events. 37 
This study shows for the first time the involvement of TLRs, expressed on macrophages in the 38 
recognition and response to Acanthamoeba trophozoites. 39 
 40 
 41 
 42 
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Introduction 43 
Acanthamoeba castellanii is a ubiquitous free-living amoeba that has been isolated from both 44 
outdoor and indoor environments. It exists as active feeding, dividing trophozoites and the 45 
dormant environmentally resistant, cyst. Despite its ability to proliferate and survive as a free 46 
living organism, Acanthamoeba is also a facultative parasite of humans, most frequently causing 47 
a painful, potentially blinding infection of the eye, called Acanthamoeba keratitis (AK), in 48 
immune-competent individuals.  Acanthamoeba is also an opportunistic parasite and in immune-49 
compromised individuals it is responsible for a often fatal infection of the brain, named 50 
granulomatous amoebic encephalitis (GAE) (1). The ability of the vast majority of immune-51 
competent humans to resist infection coupled with the susceptibility of the immune-52 
compromised demonstrates the importance of the immune system in resistance to infection.  53 
However, and surprisingly, there is little available data regarding the immune response to 54 
Acanthamoeba although approximately 50-100% of people are known to be seropositive (2). 55 
Acanthamoeba preferentially infects immune privileged sites such as the brain and the eye 56 
which are characterized by a limited regenerative capability (3). It has been demonstrated that 57 
both the innate and the adaptive immune responses are involved during Acanthamoeba infection 58 
(2, 4).  Amongst those elements of the innate immune response that have been implicated in 59 
protective immunity are the phagocytic cells, primarily neutrophils and macrophages both of 60 
which are capable of killing Acanthamoeba (5). However, macrophages have been demonstrated 61 
to persist at the site of infection (6, 7) and therefore they may be involved, not only in initiating 62 
and maintaining an effective immune response, but also may have a role in tissue repair (8). To 63 
date the majority of studies have examined the interaction between corneal epithelial cells (9Ð64 
11) and Acanthamoeba with comparatively few examining the interaction of these organisms 65 
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with macrophages. Macrophages can be either long-lived cells patrolling the hostÕs tissues 66 
(resident macrophages), or they can originate from recruited blood-derived monocytes at the 67 
site of infection (elicited macrophages) (12). Resident macrophages, strategically distributed 68 
within all tissues, are responsible for the first recognition of pathogens, through Pattern 69 
Recognition Receptors (PRRs) including Toll like receptors (TLRs).  The interaction of these 70 
PRRs with pathogen associated molecular patterns (PAMPs) is important in initiating effector 71 
mechanisms for the eradication of pathogens and also directing the developing adaptive immune 72 
response and initiating tissue repair (13). To date the role of TLRs expressed on macrophages 73 
in recognizing and responding to Acanthamoeba has not been addressed. To address this in this 74 
study, bone marrow derived (BMD) macrophages were co-incubated with either a classical 75 
laboratory strain of A. castellanii, named Neff or a clinical isolate of A. castellanii, isolated from 76 
a case of bilateral keratitis. Both strains utilised were of the T4 genotype that has been associated 77 
with the majority of human infections. The kinetics of pro-inflammatory cytokine released by 78 
macrophages upon exposure to trophozoites of A. castellanii has been quantified, and the TLRs 79 
and key signalling molecules responsible for these immunological events identified. 80 
 81 
Materials and Methods 82 
Acanthamoeba castellanii cultures 83 
Trophozoites of A. castellanii Neff strain, a classical laboratory strain, isolated from soil over 84 
60 years ago and kindly donated by the late Prof. Keith Vickerman (Glasgow, United Kingdom) 85 
and a A. castellanii genotype T4, isolated in 1992 from a patient affected by bilateral keratitis 86 
in Ancora, Italy (clinical isolate) (14Ð17) were used in this study.  Both strains were grown in a 87 
medium consisting of 0.9% w/v D-(+)-maltose monohydrate 95% (AlfaAesar, Heysham UK) 88 
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and 2% w/v mycological peptone (Oxoid, Basingstoke, UK) and supplemented with 125µg/ml 89 
of Penicillin/Streptomycin (Sigma Chemical Co, Poole, UK) and the Neff strain was also treated 90 
with 125µg/ml Amphotericin B (Sigma Chemical Co, Poole, UK). Trophozoites were cultured 91 
in 75 cm
2
 tissue culture flasks (Corning, NY, USA) and incubated at room temperature. They 92 
were used when confluent and harvested by mechanical detachment.  93 
 94 
Culture of bone marrow derived macrophages  95 
Bone marrow derived (BMD) macrophages, obtained from the femurs of either 7-weeks-old 96 
male BALB/c or C57BL/6 Toll like receptor 4  (TLR4-/-), Toll like receptor 2 (TLR2-/-), Toll 97 
like receptor 2/4 (TLR2/4-/-), myeloid differentiation primary response gene 88 (MyD88 -/-) or 98 
TIR-domain-containing adapter-inducing interferon β (TRIF-/-) deficient mice and their wild-99 
type counterparts, were used to perform the experiments. Briefly, bone marrow stem cells were 100 
flushed from the femur with 5 ml of DulbeccoÕs medium (DMEM) (Life technologies, Paisley, 101 
UK) supplemented with 20% v/v of heat inactivated foetal calf serum (HI-FCS) (Biosera, 102 
Sussex, UK), 30% v/v of L-cell conditioned medium, 2 mM L-glutamine (Sigma Chemical Co, 103 
Poole, UK), 125 U/ml Penicillin and 125 µg/ml Streptomycin and grown for 10 days, at 37¡C, 104 
5% CO2 atmosphere. L-cell conditioned medium was obtained by harvesting the metabolized 105 
medium from cultured murine fibroblastic cell line L-929. This conditioned medium provides a 106 
source of macrophage colony stimulating factor (M-CSF) necessary for the growth and 107 
differentiation of bone marrow stem cells into mature macrophages (18).  108 
 109 
 110 
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Co-incubation of BMD-macrophages with Acanthamoeba castellanii trophozoites. 111 
At day 10, macrophages were harvested with RPMI-1640 medium (Lonza Biowhittaker, 112 
Virviers, Belgium), and centrifuged at x 300 g 5 minutes (min). Pellets were re-suspended in 113 
RPMI supplemented with 10% v/v HI-FCS, 2 mM L-glutamine, 125µg/ml 100 U/ml Penicillin 114 
and 100 µg/ml Streptomycin (complete RPMI, cRPMI) and centrifuged for 5 min at x 300 g. 115 
Supernatants were discarded and macrophages were then re-suspended in cRPMI and counted 116 
using the Neubauer Chamber (Superior Marienfeld, Germany). Macrophage suspensions at 117 
required density were prepared, seeded in the appropriate vessel, and incubated over night at 118 
37¡C, 5% CO2, to allow macrophages to adhere.  119 
The day after, trophozoites were harvested by mechanical detachment. Trophozoite suspensions 120 
were centrifuged at x 360 g for 10 min and subsequently, washed once in sterile Phosphate 121 
Buffered Saline without Ca
2++ 
or Mg
2++
 or Phenol Red (PBS) (Lonza, Walkersville, USA) (x 122 
360 g 5 min) and once in cRPMI (x 360 g 5 min). Trophozoites were then suspended in cRPMI 123 
and counted using the Neubauer Chamber. Trophozoite suspensions were used for the co-124 
incubation experiments at specified ratios. Macrophages were co-incubated with trophozoite 125 
suspension in cRPMI of either the Neff strain (Neff) or the clinical isolate (clinical). 126 
 127 
Real time microscopy of a co-culture of murine BMD macrophages and trophozoites of A. 128 
castellanii at 37¡C 129 
Murine macrophages were harvested and suspended to 7 x 10
5
 cells/ml in cRPMI. 30 µl of cell 130 
suspension was added into 3 channels of the µ-slide VI0.4 (ibidi GmbH, Martinsried, Germany). 131 
After replacing the lid to cover the reservoirs, the µ-slide was incubated at 37¡C 5%CO2 for 1 132 
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h and 30 min to allow macrophages to adhere. Afterwards, 60 µl of free cell cRPMI was added 133 
to each well, and then the µ-slides were incubated at 37¡C 5%CO2 over night. After incubation 134 
cRPMI was removed from the wells, and 30 µl of either Neff or clinical trophozoites (7 x 10
5
 135 
trophozoites/ml suspensions in cRPMI) were added. In the control channel (macrophages alone) 136 
30 µl of cRPMI were applied; in the co-culture channels, 60 µl of cRPMI were then added to all 137 
wells. Prepared µ-slides were then observed, using an inverted epifluorescence microscope 138 
(Nikon, Eclipse TE300), provided with a 37¡C chamber that allowed maintenance of the 139 
samples at the appropriate temperature while images were acquired at X10, X20 or X40 140 
magnification. After manually focusing, images were acquired every 30 sec for a period of 1 h 141 
using the software MetaMorph (Molecular devices, Sunnyvale, CA, USA). Thereafter, images 142 
were processed using the programme Volocity (Perkin Elmer, Massachusetts, USA). 143 
 144 
Stimulation of BMD macrophages with specific agonists 145 
Lipopolysaccharide (LPS) from Salmonella enterica serotype abortus equi (Sigma Chemical 146 
Co, Poole, UK), the synthetic tripalmitoylated lipopeptide (PAM3CSK4) (Invivo Gen, San 147 
Diego, CA, USA), and the synthetic double stranded RNA polyinosinic-polycytidylic acid 148 
(POLY I:C) were used to stimulate macrophages via TLR4, TLR2 and TLR3, respectively as 149 
positive controls. The final concentration used in wells, was 200 ng/ml for LPS, 320 ng/ml for 150 
PAM3CSK4 and 10 µg/ml for POLY I:C. 151 
Quantitative analysis of murine cytokines production 152 
At specific time points after co-incubation, plates were centrifuged for 1 min at 480 x g, 153 
supernatants were collected and Enzyme Linked-Immuno-Sorbent Assay (ELISA) was 154 
8 
 
performed, using paired purified rat anti-mouse primary antibody and secondary biotin rat anti-155 
mouse antibody (BD Bioscience), to determine the concentration of IL-12 p40/p70 and IL-6 156 
released by murine macrophages. The optical density (OD) of each well was determined at 405 157 
nm using SpectraMax 190 microplate spectrophotometer (Molecular Devices, Sunnyvale, CA, 158 
USA). SOFTMAX PRO software (Molecular Devices, Sunnyvale, CA, USA) was used to 159 
obtain the values of OD and to calculate cytokine concentration in relation to the standard curve 160 
(BD Bioscience). Cytokine concentration was expressed in ng/ml.  161 
 162 
Statistical analyses 163 
Experiments were performed in triplicate and repeated twice. Data are shown as the mean ±	164 
standard errors of means (SEM) of 3 replicates. Statistical analyses were performed using 165 
GraphPad Prism 5 program. Data, that were normally distributed, were analysed using the 166 
parametric statistical tests one way analysis of variance (ANOVA) and studentÕs t test 167 
accordingly with the nature of experiments and of the hypothesis to be investigated. One way 168 
ANOVA was used to analyse statistical significance within several conditions (more than two) 169 
and post-hoc tests, either TukeyÕs or DunnettÕs, were applied respectively to set all pairwise 170 
comparisons or to compare each condition mean with the control. StudentÕs t test was applied 171 
to evaluate significant differences between two conditions. Differences were considered 172 
significant with a value of P<0.05. 173 
 174 
 175 
 176 
 177 
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Results 178 
In vitro real time imaging of A. castellanii infection shows cell-cell interactions between 179 
murine BMD macrophages and trophozoites of either the Neff strain or clinical isolate. 180 
Macrophages and Neff strain trophozoites were found to engage in mutual interactions a few 181 
minutes after infection. Trophozoites showed characteristic pseudopodia and amoeboid 182 
locomotion.  Macrophages were healthy, actively moving and their lamellipodia and filopodia 183 
were visible. However, macrophages were generally less motile than the trophozoites (S1-a). 184 
Neff trophozoites were observed to establish contact with macrophages and to roll on the 185 
macrophageÕs surface.  Although macrophages briefly attached to trophozoites with either 186 
lamellipodia or filopodia they were unable to maintain this contact and to phagocytose them 187 
(S1-b). Indeed, no phagocytic invagination was observed at any time during observation of up 188 
to 1 hour (S1-a and S1-b). In contrast, real time interaction between macrophages and 189 
trophozoites of the clinical isolate showed some differences in comparison with macrophage 190 
infection with the Neff strain. In this instance, trophozoites of the clinical isolate did not show 191 
rolling behaviour over macrophageÕs surface (S2-a and S2-b); nevertheless, macrophages were 192 
able to interact with trophozoites through lamellipodia and filopodia (S2-a and S2-b) and 193 
sometimes this resulted in trophozoite disruption (S2-a), but we also observed trophozoite 194 
division occurred during the observation period (S2-b).  195 
 196 
A. castellanii Neff induces IL-12 and IL-6 production in murine BMD macrophages in a 197 
time and trophozoite density dependent manner 198 
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In order to evaluate if the production of pro-inflammatory cytokines depends on trophozoite 199 
density or on duration of infection, murine macrophages were stimulated with Neff trophozoites 200 
at three different ratios of trophozoite:macrophage (ratio 1:1, 1:2, 1:10) and the production of 201 
IL-12 and IL-6 was assessed at 4, 6, 8, 10, and 24 h after infection.  202 
 203 
IL-12 production increased progressively throughout the course of the study in all trophozoite 204 
infected experimental groups, reaching the highest concentrations at 24 h post-infection 205 
compared to unstimulated control cultures. At 24 h the trophozoite/macrophage co-culture ratios 206 
of 1:1 and 1:2 had induced similar levels of IL-12 and significantly higher than the other 207 
experimental groups (22.08 ng/ml P<0.0005 and 20.92 ng/ml P<0.0005). LPS stimulated 208 
macrophages produced IL-12 in a time dependent manner, peaking at 24 h post-stimulation. No 209 
IL-12 was detectable in control macrophage cultures at any time (Fig 1-A). 210 
 211 
IL-6 production by murine macrophages co-cultured with trophozoites increased throughout the 212 
24 h time course of study and levels recorded were significantly greater from the 213 
trophozoite/macrophage co-culture ratios of 1:1 and 1:2 than control macrophage cultures from 214 
8 h. The trophozoite/macrophage co-culture ratios of 1:1 and 1:2 were equally effective at 215 
inducing IL-6 production and significantly more than a trophozoite/macrophage co-culture ratio 216 
of 1:10 (Fig 1-B). Interestingly the dynamics and profile of LPS-induced macrophage IL-6 217 
production are quite dissimilar from that induced by trophozoite co-culture. LPS induced a 218 
significantly more rapid IL-6 production than trophozoite/macrophage co-culture ratios of 1:1 219 
and 1:2 that peaked at 8 h post-stimulation. No IL-6 was detectable in non-infected macrophage 220 
cultures at any time. 221 
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A clinical isolate of A. castellanii, belonging to genotype T4, stimulates lower cytokine 222 
production than Neff, the classical laboratory strain T4 genotype. 223 
Differences in the levels of cytokines induced by macrophages co-cultured with either the Neff 224 
or the clinical strains  were investigated. Based on the effectiveness of cytokine induction in the 225 
studies above, murine BMD macrophages were infected at the ratios of 226 
trophozoites:macrophages 1:1 and 1:2. Samples were collected at 8 h and 24 h after co-227 
incubation, an early and late time point respectively.  IL-12 production by macrophages was 228 
greater following incubation with Neff strain trophozoites than the clinical isolate at both 8 h 229 
and 24 h (p<0.0005) (Fig 2-A). These results were consistent at both trophozoite/macrophage 230 
infection levels. IL-6 production by macrophages was significantly induced by Neff strain 231 
trophozoites compared with non-infected macrophage cultures at both 8 and 24 h (p<0.0005) 232 
post-infection. In addition, macrophages incubated with Neff strain trophozoites produced 233 
significantly more IL-6 than macrophages incubated with clinical strain trophozoites at both 8h 234 
and 24h (p<0.0005) post-infection. Clinical strain trophozoites failed to induce IL-6 production 235 
significantly above that produced by unstimulated control macrophages at 8 h post-infection 236 
(Fig 2-B). In addition, Neff strain trophozoites induced IL-6 at a later time point than the LPS 237 
control. 238 
	239 
Acanthamoeba-induced IL-12 and IL-6 production is MyD88-dependent and partially 240 
TRIF-dependent 241 
Studies were performed using gene-deficient mice to identify key signalling pathways involved 242 
in the induction of cytokines by Acanthamoeba. BMD macrophages were obtained from 243 
C57BL/6 wild-type mice, or C57BL/6 mice deficient in either MyD88 or TRIF genes and co-244 
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incubated with Neff strain or the clinical isolate trophozoites at ratios of 1:1 and 1:2. As positive 245 
controls macrophages were stimulated with LPS, natural TLR4 ligand, or with the synthetic 246 
double stranded RNA POLY I:C, a selective TLR3 agonist. Production of IL-12 and IL-6 was 247 
then measured at 24 h post co-culture. 248 
Significant production of IL-12 and IL-6 by WT macrophages was induced by trophozoites of 249 
either Neff strain or clinical isolate at both co-culture ratios studied (Fig 3-A1 and 3-B1). 250 
However, MyD88
-/-
 macrophages co-incubated with trophozoites of either Neff strain or clinical 251 
isolate failed to produce detectable levels of either IL-12 or IL-6 (Fig 3-A2 and 3-B2). By 252 
comparison IL-12 production was significantly inhibited though not ablated in TRIF
-/- 
253 
macrophages co-incubated with trophozoites of either the Neff strain or clinical isolate 254 
compared to WT macrophages (Fig 4ÐA1 and A2). In addition, IL-6 production by the Neff 255 
strain significantly decreased in TRIF
-/-
 macrophages (p=0.0014) (Fig 4-B1 and B2).		256 
	257 
	Acanthamoeba-induced macrophage IL-12 and IL-6 production is TLR4-dependent but 258 
TLR2-independent	259 
TLR2 and TLR4 were considered potential targets for trophozoite induced macrophage cytokine 260 
induction since they are localized on the cell surface and associated with the MyD88-dependent 261 
signalling pathway. Therefore, macrophages derived from C57BL/6 mice deficient in TLR2 or 262 
TLR4 or TLR2/TLR4 were utilized to determine their specific roles in this process. Neff strain 263 
and clinical strain trophozoites were used in co-incubation with isolated macrophages at a ratio 264 
of 1:1. As positive controls, macrophages were stimulated with either LPS or PAM3CKS4 or 265 
RNA POLY I:C. Production of IL-12 and IL-6 was then measured at 24 h after infection.	266 
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C57/BL6 WT macrophages produced IL-12 and IL-6 when induced by trophozoites of either 267 
Neff or clinical strains (Fig 5-A1 and B1). Production of these cytokines was not diminished in 268 
TLR2
-/- 
macrophages (Fig 5-A2 and B2) whereas, IL-12 production by TLR4
-/- 
macrophages 269 
was significantly lower in comparison to WT macrophages (Neff p=0.0009; clinical p=0.0002) 270 
(Fig 5-A3), and IL-6 was completed ablated (Fig 5-B3). The simultaneous absence of both TLR2 271 
and TLR4 on macrophages was characterized by significantly lower IL-12 production when co-272 
incubated with either Neff strain (p=0.0009) or clinical isolate trophozoites (p=0.0002) (Fig 5-273 
A4) and no IL-6 was produced, compared to WT macrophages (Fig 5-B4). 274 
 275 
Discussion 276 
A. castellanii is a ubiquitous free-living micro-organism, so much so that individuals are 277 
constantly exposed to these amoebae in their everyday life. Although the opportunities of 278 
becoming infected with this protist are high, few cases of facultative or opportunistic parasitism 279 
and disease have been reported. Patients with an immune deficiency are particularly susceptible 280 
to infection with these organisms and they usually present the most severe and deadly amoebic 281 
disease, GAE. On the other hand, AK can also occur in immune competent individuals 282 
predominantly, but not exclusively, in contact lens wearers (19). While, AK is generally 283 
attributed to either bad hygiene or to corneal trauma caused by the lens, a recent study 284 
demonstrating that prolonged use of contact lenses may impair innate immunity at the ocular 285 
surface provides an additional mechanisms that potentially contributes to increased incidence 286 
of AK in contact lens wearers (20, 21). Overall therefore, it is the general consensus that the 287 
immune system is critical in determining whether infection occurs following an encounter with 288 
Acanthamoeba in humans.  289 
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 290 
Our studies have shown, for the first time, the profile and kinetics of Acanthamoeba-induced 291 
IL-12 and IL-6 production in murine BMD-macrophages during co-culture with trophozoites.  292 
These cytokines, not only play important roles in the activation of the innate immune cell 293 
functions, but they are also involved in the activation and proliferation of the adaptive immune 294 
cells (22, 23). IL-12, in particular, plays a pivotal role in controlling microbial infections (24) 295 
as it stimulates IFN-γ production by natural killer (NK) cells and promotes type-1 immune 296 
responses and classical macrophage activation (25). IL-6 is known to play both ÒearlyÓ as well 297 
as a ÒlateÓ roles at the site of infection/inflammation (22). Thus in the absence of IL-6 mice are 298 
highly susceptible to infection as seen with a variety of organisms including, Listeria 299 
monocytogenes (26, 27), Candida albicans (28) and Toxoplasma gondii (29). However, IL-6 is 300 
also necessary to down-regulate ongoing inflammatory responses by inhibiting the production 301 
of TNF-α and IL-1 by macrophages (30Ð33). 302 
 303 
Acanthamoeba can grow axenically in laboratory conditions. However, this can lead to loss of 304 
virulence factors, encystment capability and reduced susceptibility to drugs (34). Therefore, we 305 
compared the ability of A. castellanii Neff strain, a classical laboratory strain, and A. castellanii 306 
isolated from a case of bilateral keratitis to induce macrophage cytokine production. This 307 
clinical strain of Acanthamoeba was chosen as it is known to be capable of infecting immune 308 
competent hosts. Interestingly, while both clinical and Neff strains induced macrophage IL-12 309 
and IL-6 production, with similar kinetics, macrophages incubated with the clinical isolate 310 
trophozoites produced significantly less cytokines than macrophages incubated with the Neff 311 
strain under similar conditions. While it could be argued that these results are predictable, as 312 
15 
 
limiting the production of pro-inflammatory cytokines would enhance the virulence of a 313 
pathogen, it would require a more comprehensive study comparing a number of clinical and 314 
laboratory isolates of the T4 genotype to establish such a relationship. Lower cytokine 315 
production by macrophages incubated with the clinical strain could be due to this strain inducing 316 
comparatively more damage to macrophages than the Neff strain, although this has not been 317 
investigated in this present study. Certainly, real time imaging experiments indicated differences 318 
in macrophage responses to the pathogenic and non-pathogenic Acanthamoeba strains. In 319 
particular, the results indicate that macrophages respond to trophozoites of the clinical isolate 320 
in a contact-dependent manner not observed with the laboratory strain, with some cytolysis 321 
observed and phagocytosis attempted.  322 
 323 
All this considered, our data demonstrate that Acanthamoeba trophozoites induce production of 324 
both IL-12 and IL-6 by murine macrophages. The higher production was observed at 24 h post 325 
co-incubation, in accordance with their role in modulating immune responses, at the highest co-326 
incubation ratios. In contrast, a recent study from our laboratories has demonstrated that 327 
Acanthamoeba trophozoites of the clinical, fail to induce pro-inflammatory cytokines, such as 328 
TNF-α, IL-6 and IL-12, by human monocyte-derived macrophages. This discrepancy could be 329 
explained by differences between murine and human cells, or experimental techniques 330 
optimised for each cell type.  This would include differences in numbers of trophozoites used 331 
in the co-incubation models, as well as the time of observation which were each optimised to 332 
allow co-culture with minimal cell death, but with sufficient interaction to induce measurable 333 
levels of cytokines (35).  In addition, we have previously demonstrated that conditioned media 334 
derived from Acanthamoeba cultures can mimic some of the observed effects on human cells, 335 
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but find conditioned media to be less effective in murine cells. These differences could be 336 
species dependent or due differences in culture conditions including media components such as 337 
the presence of absence of heat inactivated bovine calf serum. 338 
 339 
The role of innate immune receptors such as TLRs has been widely described during protist 340 
infections. TLR2 and TLR4 are the main TLRs involved in the recognition of parasitic protists 341 
such as Leishmania spp., Trypanosoma cruzi, T. gondii, Plasmodium falciparum and 342 
Entamoeba histolytica Studies have demonstrated that Acanthamoeba trophozoites can activate 343 
TLR4 expressed on corneal epithelial cells, inducing pro-inflammatory cytokines and 344 
chemokines at the ocular surface (10, 36). The activation of TLRs at the ocular surface by 345 
Acanthamoeba and the release of cytokines and chemokines, can be the triggering event for the 346 
recruitment of innate immune cells such as macrophages and neutrophils (37).  347 
 348 
The results described herein demonstrate that recognition of Acanthamoeba trophozoites is 349 
predominately through TLR4 that induces MyD88 dependent, with a small contribution of TRIF 350 
dependent signalling culminating in cytokine production. This is in accordance with the unique 351 
ability of TLR4 to induce both MyD88-dependent and TRIF-dependent signalling pathways 352 
(38). Our study demonstrates TLR4 as the main receptor involved in the recognition and 353 
response to Acanthamoeba trophozoites, in macrophages and this is in agreement with studies 354 
utilising corneal epithelial cells (10, 36). 355 
 356 
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The results obtained suggest that Acanthamoeba might present on its surface, molecules that are 357 
recognized by TLR4, thus inducing an innate immunological response. GPI-anchors are highly 358 
expressed in several parasitic protists (39) and are highly immunogenic, inducing a response by 359 
cells of both the myeloid and lymphoid lineages (40). These structures are recognized by TLRs, 360 
mainly TLR2, TLR4 and are therefore considered as protist PAMPs (41). According to an early 361 
study, the plasma membrane of A. castellanii is composed for 31% of its mass by 362 
lipophosphoglycans (LPG) (42). This data has been confirmed and further characterised by a 363 
more recent study using Gas Chromatography-Mass Spectrometry techniques, where the 364 
chemical nature of Acanthamoebic LPG was identified and recognized as 365 
glycoinositolphosphosphingolipids (GIPSL) (43). Although it has yet to be confirmed, these 366 
structural moieties are strong candidates to be the Acanthamoeba-associated molecular patterns 367 
that stimulate the TLRs expressed on macrophages.  368 
 369 
The studies described herein used murine bone marrow derived macrophages as these can be 370 
generated consistently in high numbers from both wild-type and gene-deficient mice. The results 371 
are intuitively relevant to systemic infections and most tissues where macrophages are known 372 
to be resident.  Although macrophages have are known to be present within the eye, they are 373 
predominantly found adjacent to the pigment epithelium of the iris, the ciliary body and in the 374 
retina.  It was previously thought that antigen presenting cells such as macrophages and DCs 375 
are generally not present in the cornea which is the site of AK.   However, a series of recent 376 
studies have demonstrated the presence of resident macrophages, albeit in low numbers within 377 
both murine and human cornea and reviewed (1). Furthermore, these macrophages have been 378 
found to be important in a murine model of Pseudomonas aeruginosa infection. Thus F4/80
+
 379 
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cells present in the corneal stroma expressing TLR4, TLR5 and TLR2 where found to respond 380 
to Pseudomonas by releasing of cytokines in a TLR4/TIRAP/MyD88 and TLR4/TRIF- Nf-kB 381 
translocation dependent manner (2).  Thus the studies described herein could also have relevance 382 
to AK. 383 
 384 
In conclusion, we have demonstrated that Acanthamoeba interact and activate macrophages, 385 
inducing the production of IL-12 and IL-6 in a time and density dependent manner. Furthermore, 386 
the clinical isolate examined in this study induces lower cytokine production by macrophages, 387 
in comparison with the classical laboratory strain Neff. Both strains induce IL-12 and IL-6 388 
production by macrophage through a predominantly TLR-4/MyD88 dependent mechanism. The 389 
study of the immunological mechanisms involved in these rare, but insidious infectious diseases, 390 
is essential to develop appropriate therapeutic strategies. Indeed the modulation of receptor 391 
activity and of signalling pathways at the site of infection, might not only help control infection 392 
but also mitigate over exuberant immune/inflammatory responses. 393 
 394 
 395 
 396 
 397 
 398 
 399 
 400 
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Figure Legends 401 
Fig 1. Release of IL-12 (A) and IL-6 (B) at 4, 6, 8, 10, 24 h after co-incubation with A. 402 
castellanii Neff trophozoites. 1 x 10
6
 murine macrophages, obtained from BALB/c mice, were 403 
challenged with either 1x10
6
 (Ratio 1:1) or 5x10
5
 (Ratio 1:2) or 1x10
5
 (Ratio 1:10) trophozoites 404 
of A. castellanii Neff strain. LPS was used as a positive control at a concentration of 200 ng/ml, 405 
whereas uninfected macrophages (Control) were considered the negative control. Experiments 406 
were repeated three times. Results represent the mean ± standard error of n=6. Two way 407 
ANOVA could not be applied, since the interaction between the stimuli and time was 408 
statistically significant and the statistical analysis for the time and stimuli effects are therefore 409 
difficult to interpret. For this reason, one way ANOVA was applied for each time points. 410 
TukeyÕs multiple comparison test was performed to evaluate differences within the conditions 411 
means at each time point. In the graphs, significances within the different conditions are 412 
indicated as follow: for values of p<0.005 **; p<0.0005 ***. Note that trophozoite/macrophage 413 
infection higher ratios induce higher cytokine production and IL-6 and IL-12 production peaks 414 
at 24 hrs. 415 
 416 
Fig 2. Release of IL-12 (A) and IL-6 (B) at 8 and 24 h after co-incubation with A. castellanii 417 
trophozoites. 1x10
6
 murine macrophages, obtained from BALB/c mice, were challenged with 418 
either 1x10
6
 or 5x10
5
 trophozoites of either the Neff strain (respectively Neff ratio 1:1 and Neff 419 
ratio 1:2) or clinical isolate (respectively Clinical ratio 1:1 and Clinical ratio 1:2). LPS, at a 420 
concentration of 200 ng/ml, (LPS) was used as a positive control, whereas uninfected 421 
macrophages (Control) were considered the negative control. The experiment was repeated 422 
twice. Results represent the mean ± standard error of n=3. One way ANOVA was applied for 423 
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each time point and TukeyÕs multiple comparison test was performed to evaluate differences 424 
within the conditions means at each time point. In the graphs, significant differences between 425 
Neff and clinical strains are indicated as follow: for values of p<0.05 ¡; p<0.0005 ¡¡¡. Values 426 
below the detectable levels are indicated in the graphs as ND (not detected). Note that 427 
Acanthamoeba Neff strain induces higher levels of macrophage pro-inflammatory cytokines 428 
than Acanthamoeba clinical isolates. This event is observed both at the early time points (8 hrs 429 
post co-incubation) and later time points (24 hrs post co-incubation). 430 
 431 
Fig 3. Release of IL-12 (A) and IL-6 (B): comparison between C57BL/6 WT (A1 and B1) 432 
and C57BL/6 MyD88
-/- 
(A2 and B2) macrophages at 24 h after co-incubation with 433 
Acanthamoeba trophozoites. 1x10
6
 murine macrophages, obtained from either C57BL/6 WT 434 
or C57BL/6 MyD88
-/- 
mice, were challenged with either 1x10
6 
or 5x10
5 
trophozoites of either 435 
A. castellanii Neff strain (respectively Neff 1:1 and Neff 1:2) or clinical isolate (respectively 436 
clinical 1:1 and 1:2). LPS and POLY I:C at respectively 200 ng/ml (LPS) and 10 µg/ml (POLY 437 
I:C) were used to stimulate macrophages as positive controls. Uninfected macrophages 438 
(Control) were considered the negative control. The experiment was performed twice. Results 439 
represent the mean ± standard error of n=3. StudentÕs t-test was applied to evaluate differences 440 
between C57BL76 WT and the C57BL/6 MyD88
-/-
 macrophage cytokine production. Values 441 
below the detectable levels are indicated in the graphs as ND (not detected). IL-12 and IL-6 442 
production in trophozoites/MyD88
-/-
 macrophages co-incubation is completely ablated in 443 
comparison to trophozoites/WT macrophages co-incubation, suggesting that the production of 444 
these pro-inflammatory cytokines by macrophages, in response to Acanthamoeba, is MyD88-445 
dependent.  446 
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Fig 4. Release of IL-12 (A) and IL-6 (B): comparison between C57BL/6 WT (A1 and B1) 447 
and C57BL/6 TRIF
-/-
 (A2 and B2) macrophages at 24 h after co-incubation with 448 
Acanthamoeba trophozoites. 1x10
6
 murine macrophages, obtained from either C57BL/6 WT 449 
or C57BL/6 TRIF
-/-
 mice, were challenged with either 1x10
6
 or 5x10
5
 trophozoites of either A. 450 
castellanii Neff strain (respectively Neff 1:1 and Neff 1:2) or clinical isolate (respectively 451 
clinical 1:1 and clinical 1:2). LPS and POLY I:C at respectively 200 ng/ml (LPS) and 10 µg/ml 452 
(POLY I:C) were used to stimulate macrophages as positive controls. Uninfected macrophages 453 
(Control) were considered the negative control. The experiment was performed twice. Results 454 
represent the mean ± standard error of n=3. StudentÕs t-test was applied to evaluate differences 455 
between C57BL76 WT and the C57BL/6 TRIF
-/- 
macrophages. Values below the detectable 456 
levels are indicated in the graphs as ND (not detected). IL-12 and IL-6 production in 457 
trophozoites/TRIF
-/-
 macrophages co-incubation is significantly diminished in comparison with 458 
trophozoites/WT macrophages co-incubation condition suggesting that the production of these 459 
pro-inflammatory cytokines by macrophages in response to Acanthamoeba, might be in part 460 
TRIF-dependent, although this does not appear to be the main signalling pathway involved 461 
during Acanthamoeba stimulation.  462 
 463 
Fig 5. Release of IL-12 (A) and IL-6 (B): comparison between C57BL/6 WT (A1 and B1) 464 
and C57BL/6 TLR2-/- (A2 and B2), TLR4-/- (A3 and B3), TLR2/4-/- (A4 and B4) 465 
macrophages 24 h after co-incubation with Acanthamoeba trophozoites. 1x10
6
 murine 466 
macrophages, obtained from C57BL/6 WT and KO mice, were challenged with 1x10
6
 467 
trophozoites of either A. castellanii Neff strain (Neff) or clinical isolate (Clinical). LPS, 468 
PAM3CSK4 and POLY I:C at respectively 200 ng/ml, 320 ng/ml and 10 µg/ml were used to 469 
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stimulate macrophages as positive controls. Uninfected macrophages (Control) were considered 470 
the negative control. The experiment was performed twice. Results represent the mean ± 471 
standard error of n=3. StudentÕs t-test was applied to evaluate differences between C57BL76 472 
WT and the C57BL/6 TLR2-/-, TLR4-/- and TLR2/4-/-  conditions. Values below the detectable 473 
levels are indicated in the graphs as ND (not detected). IL-12 and IL-6 production in 474 
trophozoites/TLR2-/- macrophages co-incubation was not significantly diminished in 475 
comparison with trophozoites/WT macrophages co-incubation condition, suggesting that the 476 
production of these pro-inflammatory cytokines by macrophages in response to Acanthamoeba 477 
is not TLR2-dependent. On the other hand, in the absence of TLR4, trophozoites-induced IL-12 478 
production by macrophages was significantly decreased, whereas IL-6 production was 479 
completely ablated. The same pattern was observed when both TLR2 and TLR4 were not 480 
expressed. Therefore, TLR4 appeared to be the main TLR involved in the recognition and 481 
response to A. castellanii. 482 
 483 
 484 
 485 
 486 
 487 
 488 
 489 
 490 
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